Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
lymphangioleiomyomatosis
MeSH D018192 - lymphangioleiomyomatosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008203:
Lymphangiomyoma
0 Companies
0 Drugs
Success rate
D054973:
Perivascular epithelioid cell neoplasms
0 Companies
0 Drugs
Success rate
D018192:
Lymphangioleiomyomatosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
57
%
8/14
Phase 2
13
%
2/15
Phase 3
0
%
0/2
Approved:
0
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use